发明名称 Tie2 activator, vascular endothelial growth factor (vegf) inhibitor, anti-angiogenic agent, agent for maturing blood vessels, agent for normalizing blood vessels, agent for stabilizing blood vessels, and pharmaceutical composition
摘要 To provide a Tie2 activator, a vascular endothelial growth factor (VEGF) inhibitor, an angiogenesis inhibitor, a vascular maturing agent, a vascular normalizing agent and a vascular stabilizing agent, and a pharmaceutical composition having high safety, and an excellent Tie2 activating effect, vascular endothelial growth factor (VEGF) inhibitory effect, angiogenesis inhibitory effect, vascular maturing effect, vascular normalizing effect, and vascular stabilizing effect. A Tie2 activator, a vascular endothelial growth factor (VEGF) inhibitor, an angiogenesis inhibitor, a vascular maturing agent, a vascular normalizing agent and a vascular stabilizing agent, and a pharmaceutical composition containing, as an active ingredient, a hawthorn extract, a starfruit extract, a shellflower extract, a lotus extract, a rooibos extract, an Indian date extract, a Chinese quince extract, a Psidium guava extract, a long pepper extract, a Quillaja extract, a Kouki extract, a ginkgo extract, an oyster extract, a turmeric extract, a chrysanthemum extract, a jujube extract, a Chinese wolfberry extract, a chamomile extract, or a Butcher's Broom extract, or any combination thereof.
申请公布号 EP2857032(A3) 申请公布日期 2015.07.15
申请号 EP20140003460 申请日期 2011.10.28
申请人 MARUZEN PHARMACEUTICALS CO., LTD. 发明人 OHTO, NOBUAKI;KISO, AKINORI
分类号 A61K36/73;A61K35/618;A61K36/00;A61K36/16;A61K36/18;A61K36/185;A61K36/28;A61K36/287;A61K36/48;A61K36/53;A61K36/61;A61K36/62;A61K36/67;A61K36/725;A61K36/734;A61K36/815;A61K36/88;A61K36/9066;A61P9/00;A61P43/00 主分类号 A61K36/73
代理机构 代理人
主权项
地址